C. Gerlinger, and T. Schmelter. Pharmaceutical statistics, 10 (5):
410-3(2011)6376<m:linebreak></m:linebreak>MDCI; Tests d'equivalència; Mesures de resultats.
M. Bradburn, J. Deeks, J. Berlin, and A. Localio. Statistics in medicine, 26 (1):
53-77(January 2007)6691<m:linebreak></m:linebreak>LR: 20071115; GR: U18 HS10399/HS/AHRQ HHS/United States; JID: 8215016; 0 (Pharmaceutical Preparations); ppublish;<m:linebreak></m:linebreak>Metaanàlisi.
D. Capellà, C. Pedrós, X. Vidal, and J. Laporte. Drug safety : an international journal of medical toxicology and drug experience, 25 (1):
7-19(January 2002)6826<br/>LR: 20061115; JID: 9002928; 0 (Pharmaceutical Preparations); RF: 54; ppublish;<br/>Disseny; Tipus d'estudis; Observacionals; Farmacoepidemiologia.
M. Brookhart, J. Rassen, and S. Schneeweiss. Pharmacoepidemiology and drug safety, 19 (6):
537-54(June 2010)5676<m:linebreak></m:linebreak>GR: 1 K01 HS018088/HS/AHRQ HHS/United States; GR: 290-2005-0016-I-TO3-WA1/PHS HHS/United States; GR: K25AG027400/AG/NIA NIH HHS/United States; JID: 9208369; NIHMS205457; OID: NLM: NIHMS205457 Available on 06/01/11; OID: NLM: PMC2886161 Available on 06/01/11; ppublish;<m:linebreak></m:linebreak>Variables instrumentals.
M. Levenson, and L. Yue. Journal of biopharmaceutical statistics, 23 (1):
110-21(January 2013)7227<m:linebreak></m:linebreak>JID: 9200436; ppublish;<m:linebreak></m:linebreak>Propensity score; Normativa.
Y. Arimone, B. Bégaud, G. Miremont-Salamé, A. Fourrier-Réglat, M. Molimard, N. Moore, and F. Haramburu. Journal of clinical epidemiology, 59 (3):
308-14(March 2006)4201<m:linebreak></m:linebreak>LR: 20061115; PUBM: Print; JID: 8801383; 0 (Pharmaceutical Preparations); 2004/01/13 received; 2004/10/20 revised; 2005/08/01 accepted; ppublish;<m:linebreak></m:linebreak>Mesures d'associació.